All Article Listing | Medicap

Health News

At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.

New Drug Application for Amitiza Approved

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals USA, Inc. announced today that the FDA has approved Sucampo’s supplemental new drug application (sNDA) for AMITIZA ® (lubiprostone) (24 mcg twice daily) as the first and only oral medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.

REFINE

medications
- - (-) Remove Amitiza filter Amitiza
conditions
- - (-) Remove Neuromuscular Disease filter Neuromuscular Disease
    (-) Remove Chronic Pain Conditions filter Chronic Pain Conditions
  - Gastrointestinal (1) Apply Gastrointestinal filter
    Constipation (1) Apply Constipation filter